Holen Sie sich die Stockscreener-App
1.00
2.35%
0.023
Handel nachbörslich:
.99
-0.01
-1.00%
Schlusskurs vom Vortag:
$0.977
Offen:
$0.9769
24-Stunden-Volumen:
170.25K
Relative Volume:
0.20
Marktkapitalisierung:
$48.54M
Einnahmen:
$19.94M
Nettoeinkommen (Verlust:
$-37.37M
KGV:
-0.9615
EPS:
-1.04
Netto-Cashflow:
$-33.38M
1W Leistung:
+14.52%
1M Leistung:
-38.27%
6M Leistung:
-18.03%
1J Leistung:
-49.24%
1-Tages-Spanne:
$0.968
$1.02
1-Wochen-Bereich:
$0.8733
$1.03
52-Wochen-Spanne:
$0.595
$2.38
Werewolf Therapeutics Inc Stock (HOWL) Company Profile
Firmenname
Werewolf Therapeutics Inc
Sektor
Branche
Telefon
617-952-0555
Adresse
200 TALCOTT AVENUE, WATERTOWN
Vergleichen Sie HOWL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HOWL
Werewolf Therapeutics Inc
|
1.00 | 47.42M | 19.94M | -37.37M | -33.38M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.61 | 109.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.19 | 82.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.23 | 58.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
911.98 | 56.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.77 | 43.62B | 447.02M | -1.18B | -906.14M | -6.1812 |
Werewolf Therapeutics Inc Stock (HOWL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-03 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-08-24 | Eingeleitet | Wedbush | Outperform |
| 2023-06-06 | Fortgesetzt | Jefferies | Buy |
| 2021-09-10 | Eingeleitet | BofA Securities | Buy |
| 2021-05-25 | Eingeleitet | Evercore ISI | Outperform |
| 2021-05-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-05-25 | Eingeleitet | Jefferies | Buy |
| 2021-05-25 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Werewolf Therapeutics Inc Aktie (HOWL) Neueste Nachrichten
Aug Mood: Is Werewolf Therapeutics Inc. stock ready for breakoutWeekly Trade Recap & Daily Technical Stock Forecast Reports - moha.gov.vn
Why retail investors pile into Werewolf Therapeutics Inc. stockBreakout Watch & Verified Momentum Watchlists - moha.gov.vn
Werewolf Therapeutics (HOWL) 10% owners sell $179k in stock By Investing.com - Investing.com Australia
Evnin Luke sells Werewolf Therapeutics (HOWL) shares for $115k By Investing.com - Investing.com South Africa
MPM BioVentures sells Werewolf Therapeutics (HOWL) shares for $179k By Investing.com - Investing.com Nigeria
Evnin Luke sells Werewolf Therapeutics (HOWL) shares for $115k - Investing.com
MPM BioVentures sells Werewolf Therapeutics (HOWL) shares for $179k - Investing.com
Werewolf Therapeutics (HOWL) 10% owners sell $179k in stock - Investing.com India
A Look at Werewolf Therapeutics Inc (HOWL) Shares in the Recent Past Indicates Growth - Setenews
Head-To-Head Contrast: Werewolf Therapeutics (NASDAQ:HOWL) versus X4 Pharmaceuticals (NASDAQ:XFOR) - Defense World
Werewolf Therapeutics (HOWL) 10% owner sells $147,912 in stock By Investing.com - Investing.com Australia
Werewolf Therapeutics (HOWL) 10% owner sells $147,912 in stock - Investing.com
Chmn Evnin Sells 102,753 ($94.9K) Of Werewolf Therapeutics Inc [HOWL] - TradingView
[Form 4] Werewolf Therapeutics, Inc. Insider Trading Activity - Stock Titan
Predicting Werewolf Therapeutics Inc. trend using moving averagesJuly 2025 Chart Watch & Weekly Watchlist for Hot Stocks - newser.com
Werewolf Therapeutics Inc. stock trend forecastEarnings Trend Report & Low Risk Entry Point Tips - newser.com
Werewolf Therapeutics (NASDAQ:HOWL) Price Target Cut to $7.00 by Analysts at Bank of America - Defense World
What MACD signals say about Werewolf Therapeutics Inc.Portfolio Performance Report & High Return Trade Guides - newser.com
B of A Securities Maintains Werewolf Therapeutics (HOWL) Buy Recommendation - Nasdaq
Werewolf therapeutics (HOWL) sees $200k+ in sales by MPM related entities - Investing.com South Africa
Evnin Luke sells Werewolf Therapeutics (HOWL) shares worth $128k By Investing.com - Investing.com Nigeria
Mpm Bioventures sells Werewolf Therapeutics (HOWL) stock for $200,665 By Investing.com - Investing.com Nigeria
Evnin Luke sells Werewolf Therapeutics (HOWL) shares worth $128k - Investing.com
Owner Gadicke Sells 209,652 ($200.7K) Of Werewolf Therapeutics Inc [HOWL] - TradingView
Owner MPM Asset Management Investors BV2014 LLC Files To Sell 4,479 Of Werewolf Therapeutics Inc [HOWL] - TradingView
Owner MPM Asset Management LLC Files To Sell 20,597 Of Werewolf Therapeutics Inc [HOWL] - TradingView
Views of Wall Street’s Leading Experts on Werewolf Therapeutics Inc - Setenews
Mpm Bioventures sells Werewolf Therapeutics (HOWL) stock for $200,665 - Investing.com
Will Werewolf Therapeutics Inc. price bounce be sustainableRisk Management & Free Community Consensus Stock Picks - newser.com
How Werewolf Therapeutics Inc. stock performs after earningsSwing Trade & Daily Price Action Insights - newser.com
Why Werewolf Therapeutics Inc. stock is rated strong buyMarket Sentiment Report & Trade Opportunity Analysis Reports - Fundação Cultural do Pará
Werewolf Therapeutics Inc. stock trendline breakdown2025 Price Momentum & Consistent Income Trade Ideas - newser.com
Werewolf Therapeutics’ Promising Study on WTX-124 in Cancer Treatment - MSN
Will Werewolf Therapeutics Inc. stock recover faster than marketFed Meeting & Low Drawdown Trading Techniques - newser.com
Advanced analytics toolkit walkthrough for Werewolf Therapeutics Inc.Market Growth Summary & Precise Swing Trade Alerts - newser.com
Evnin Luke, director at Werewolf Therapeutics, sells $154k in HOWL By Investing.com - Investing.com South Africa
Werewolf Therapeutics (HOWL) 10% owners sell $241k in stock By Investing.com - Investing.com Nigeria
Mpm Bioventures sells Werewolf Therapeutics (HOWL) shares for $241k By Investing.com - Investing.com UK
Finanzdaten der Werewolf Therapeutics Inc-Aktie (HOWL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
1.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):